On 25 February 2015, Williams Companies, Inc. (NYSE:WMB) has filed its Annual Report on Form 10-K for the year ended Dec. 31, 2014, with the Securities and Exchange Commission. On Friday shares of Williams Companies, Inc. (NYSE:WMB) closed at $49.04. Company’s sales growth for last 5 years was 7.70% and EPS growth for next 5 years is recorded as 6.19%.
Cyclacel Pharmaceuticals (NASDAQ:CYCCP) announced a quarterly dividend on Tuesday, February 24th. Investors of record on Friday, April 17th will be paid a dividend of 0.15 per share on Friday, May 1st. This represents a $0.60 annualized dividend and a dividend yield of 8.57%. The ex-dividend date is Wednesday, April 15th. Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) in last trading activity advanced 37.61% to close at $1.50. Company weekly performance is 89.87% while its quarterly performance stands at -50.17%. Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) is -63.77% away from its 52 week high.
QLT Inc. (NASDAQ:QLTI) reported financial results, for the fourth quarter and year ended December 31, 2014. Unless otherwise specified, all amounts are reported in U.S. dollars and in accordance with U.S. GAAP. R&D expenses relate to QLT’s synthetic retinoid program. During the fourth quarter of 2014, R&D expenses were $2.1 million, compared to $4.8 million for the same period in 2013. On last trading day QLT Inc. (NASDAQ:QLTI) advanced 1.01% to close at $4.02. Its volatility for the week is 2.90% while volatility for the month is 3.14%. QLTI’s EPS growth for past 5 years was -33.60%. QLT Inc. (NASDAQ:QLTI) monthly performance is -6.73%.
UQM Technologies Inc. (NYSEMKT:UQM) announced it has reached a significant milestone with the official certification for the ISO 14001 standard. ISO 14001 maps out a framework for a company to follow to establish an effective Environmental Management System (EMS). UQM Technologies Inc. (NYSEMKT:UQM) has 0.10% insider ownership while its institutional ownership stands at 17.80%. In last trading activity company’s stock closed at $1.06.
Solazyme, Inc. (NASDAQ: SZYM) announced results for the fourth quarter and full year ended December 31, 2014. “Although 2014 was a challenging year, we made great strides against our commercialization and production goals, including launching Encapso™ and our AlgaVia™ microalgae food ingredients, and starting up operations at our Clinton/Galva and SB Oils Moema facilities,” said Jonathan Wolfson, CEO of Solazyme. “We ended 2014 by demonstrating fully integrated operations at Moema and are confident that we will turn the corner to consistent and reliable operations as well. On last trading day Solazyme, Inc. (NASDAQ:SZYM) advanced 0.38% to close at $2.67. Its volatility for the week is 6.47% while volatility for the month is 6.85%. SZYM’s sales growth for past 5 years was 113.40% and its EPS growth for past 5 years was -47.40%. Solazyme, Inc. (NASDAQ:SZYM) monthly performance is 26.54%.